Holen Sie sich die Stockscreener-App
62.16
0.57%
0.4594
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt GEHC?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$61.70
Offen:
$62.34
24-Stunden-Volumen:
107.98K
Relative Volume:
0.03
Marktkapitalisierung:
$28.27B
Einnahmen:
$20.98B
Nettoeinkommen (Verlust:
$1.98B
KGV:
14.88
EPS:
4.177
Netto-Cashflow:
$1.52B
1W Leistung:
+1.65%
1M Leistung:
-15.21%
6M Leistung:
-17.24%
1J Leistung:
-16.27%
1-Tages-Spanne:
$61.88
$62.48
1-Wochen-Bereich:
$61.13
$64.35
52-Wochen-Spanne:
$58.75
$89.77
Ge Healthcare Technologies Inc Stock (GEHC) Company Profile
Firmenname
Ge Healthcare Technologies Inc
Sektor
Branche
Telefon
833-735-1139
Adresse
500 WEST MONROE STREET, CHICAGO
Compare GEHC vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GEHC
Ge Healthcare Technologies Inc
|
62.16 | 28.07B | 20.98B | 1.98B | 1.52B | 4.177 |
ABT
Abbott Laboratories
|
83.58 | 143.80B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
286.77 | 108.22B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
74.86 | 95.70B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.76 | 79.33B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.79 | 44.43B | 6.30B | 1.07B | 1.09B | 1.8406 |
Ge Healthcare Technologies Inc Stock (GEHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-15 | Herabstufung | UBS | Neutral → Sell |
| 2025-10-13 | Eingeleitet | Barclays | Equal Weight |
| 2025-10-07 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-05-05 | Hochstufung | UBS | Sell → Neutral |
| 2025-03-11 | Hochstufung | Goldman | Neutral → Buy |
| 2025-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2024-09-26 | Herabstufung | UBS | Neutral → Sell |
| 2024-09-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-09-09 | Eingeleitet | JP Morgan | Neutral |
| 2024-08-06 | Eingeleitet | Stifel | Buy |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-02-15 | Eingeleitet | HSBC Securities | Buy |
| 2024-02-12 | Hochstufung | UBS | Sell → Neutral |
| 2023-11-30 | Eingeleitet | Jefferies | Hold |
| 2023-11-27 | Herabstufung | UBS | Neutral → Sell |
| 2023-09-19 | Eingeleitet | Citigroup | Buy |
| 2023-08-25 | Eingeleitet | Argus | Buy |
| 2023-08-16 | Eingeleitet | Wells Fargo | Overweight |
| 2023-07-31 | Eingeleitet | BofA Securities | Neutral |
| 2023-06-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-05-16 | Eingeleitet | Oppenheimer | Outperform |
| 2023-04-26 | Eingeleitet | UBS | Neutral |
| 2023-04-19 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-10 | Eingeleitet | BTIG Research | Neutral |
| 2023-03-13 | Eingeleitet | Evercore ISI | Outperform |
| 2023-02-17 | Eingeleitet | Mizuho | Buy |
| 2023-01-19 | Eingeleitet | Redburn | Buy |
Alle ansehen
Ge Healthcare Technologies Inc Aktie (GEHC) Neueste Nachrichten
Early users of AI cancer tool cut planning time from 7 days to 7 minutes - Stock Titan
Is Wall Street Bullish or Bearish on GE HealthCare Technologies Stock? - Barchart.com
GE HealthCare (GEHC) director Anne T. Madden receives stock unit awards - Stock Titan
GE HealthCare (NASDAQ: GEHC) director granted 3,586 restricted stock units in equity award - Stock Titan
GE HealthCare (NASDAQ: GEHC) director Culp receives restricted and deferred stock units - Stock Titan
GE HealthCare (NASDAQ: GEHC) director receives 3,586 RSU grant in Form 4 filing - Stock Titan
GE HealthCare shareholders back board, governance and compensation - TipRanks
GE HealthCare shareholders elect board, approve executive pay and auditor - Investing.com
GE HealthCare Technologies Inc. stock falls Monday, underperforms market - MarketWatch
GE HealthCare (NASDAQ: GEHC) holders approve directors, pay plan and Deloitte - Stock Titan
A Look At GE HealthCare Technologies (GEHC) Valuation After Recent Share Price Weakness - Yahoo Finance UK
GEHC Launches MIM ComboTherapy for GYN Cancer Radiation Planning - The Globe and Mail
GE HealthCare next-gen SIGNA MR technology helps advance research discovery and translate innovation into clinical impact - BioSpace
GE HealthCare shares fall after earnings miss and lowered outlook - MSN
Elderly Care Technology Market to Reach USD 93.4 Billion by 2035 - openPR.com
GE HealthCare outlines 2026 adjusted EPS $4.80-$5.00 and $1.6B free cash flow amid $250M inflation headwind - MSN
GE HealthCare stock (US36266G1076): Medical imaging leader faces headwinds in 2026 - AD HOC NEWS
Does GE HealthCare’s New Advanced Imaging Segment and Executive Shuffle Change The Bull Case For GEHC? - Sahm
symbol__ Stock Quote Price and Forecast - CNN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against GE HealthCare Technologies Inc. (GEHC) And Encourages Investors to Reach Out - ACCESS Newswire
GE HealthCare Technologies Inc. stock rises Friday, outperforms market - MarketWatch
GEHCGE HealthCare Technologies Inc Stock Price and Quote - Finviz
Computer Vision in Healthcare Market Report 2026: Revenue Expected to Surpass $33.4 Billion by 2036 - GlobeNewswire Inc.
GE HealthCare hits one-year low as inflationary environment forces guidance cut - msn.com
GEHC Stock Price, Quote & Chart | GE HEALTHCARE TECHNOLOGY (NASDAQ:GEHC) - ChartMill
Strong Cash Yield: Is GE HealthCare Technologies Stock A Buy? - Trefis
With Strong Cash Flow, GE HealthCare Technologies Stock Poised to Rise? - Trefis
GE HealthCare drops after cutting outlook on war-related woes - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
GE Healthcare Directors Make Bold Insider Moves Signaling Growing Confidence - TipRanks
Ge healthcare director Stromberg buys $61,689 stock - Investing.com
Ge healthcare director Stromberg buys $61,689 stock By Investing.com - Investing.com South Africa
GE HealthCare Technologies(GEHC.US) Director Buys US$5 Million in Common Stock - Moomoo
GE HealthCare Announces First Patient Dosed in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent Under FDA Fast Track Designation, Further Advancing Its Innovation Pipeline of Novel Imaging Agents - Quantisnow
Director William Stromberg buys GE HealthCare (GEHC) stock - Stock Titan
GE HealthCare (GEHC) director Culp buys 80,805 shares in open market - Stock Titan
GE HealthCare Technologies AGM: Shareholders Elect Directors, Approve Pay; Tariff Mitigation in Focus - Barchart.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GE HealthCare Technologies Inc.GEHC - PR Newswire
Number of shareholders of GE HealthCare Technologies Inc. – NASDAQ:GEHC - TradingView
A Look At GE HealthCare Technologies (GEHC) Valuation After Recent Segment Changes And Earnings Developments - Sahm
GEHC Q1 earnings miss estimates, revenues beat, net margin declines - MSN
GE HealthCare Technologies Inc. stock rises Wednesday, still underperforms market - MarketWatch
Emerging Growth Patterns Driving Rapid Expansion in the AI-Enabled Imaging Solutions Market - openPR.com
GE HealthCare’s Q1 Earnings Call: Our Top 5 Analyst Questions - The Globe and Mail
GE HealthCare (GEHC) executive Catherine Estrampes details stock and option stakes - Stock Titan
Is GE HealthCare (GEHC) the Best Healthcare AI Stock to Buy According to Analysts? - Insider Monkey
MSN Money - MSN
GE HealthCare announces cash dividend for first quarter of 2026 - Quantisnow
8 Best Healthcare AI Stocks to Buy According to Analysts - Insider Monkey
Jim Cramer Can’t Believe What’s Happening With GE Healthcare (GEHC) - Insider Monkey
7 New 5-Star Stocks This Week - Morningstar
Finanzdaten der Ge Healthcare Technologies Inc-Aktie (GEHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.07%
2.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):